These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2949404)

  • 1. Immunoregulatory mechanisms in cyclosporine-treated renal allograft recipients.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplantation; 1987 Feb; 43(2):205-10. PubMed ID: 2949404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1991 Feb; 51(2):338-42. PubMed ID: 1825242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
    Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD
    Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful transplantation of cyclosporine-treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatches.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplantation; 1985 Dec; 40(6):615-9. PubMed ID: 3907031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients.
    Reinsmoen NL; Kaufman D; Matas A; Sutherland DE; Najarian JS; Bach FH
    Transplantation; 1990 Nov; 50(5):783-90. PubMed ID: 2146784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor cell activity of cells infiltrating rat renal allografts prolonged by perioperative administration of extracted histocompatibility antigen and cyclosporine.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):708-13. PubMed ID: 2933856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in phenotypically defined T helper inducer cells (T4+4B4+) and increase in T suppressor effector cells (T8+2H4+) in stable renal allograft recipients.
    Ramos EL; Turka LA; Leggat JE; Wood IG; Milford EL; Carpenter CB
    Transplantation; 1989 Mar; 47(3):465-71. PubMed ID: 2522253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the autologous mixed lymphocyte reaction in kidney transplantation.
    Fuller L; Flaa C; Jaffe D; Strauss J; Kyriakides GK; Miller J
    J Clin Invest; 1983 May; 71(5):1322-30. PubMed ID: 6222068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1988 Jan; 45(1):37-40. PubMed ID: 3276059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial immune evaluation of cyclosporine- and placebo-treated multiple sclerosis patients.
    Kerman RH; Wolinsky JS; Nath A; Sears ES
    J Neuroimmunol; 1988 Jul; 18(4):325-31. PubMed ID: 2968363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of suppressor cells in cyclosporine-treated allograft recipients.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1580-3. PubMed ID: 2950632
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.
    Reinsmoen NL; Matas AJ
    Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of cyclosporine in living-related renal transplantation. Donor-specific hyporesponsiveness and steroid withdrawal.
    Flechner SM; Kerman RH; Van Buren CT; Epps L; Kahan BD
    Transplantation; 1984 Dec; 38(6):685-91. PubMed ID: 6239415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro donor-specific hyporesponsiveness and T cell subsets in renal allograft recipients.
    Bas J; Mestre M; Griñó JM; Massip E; Castelao AM; Romeu A; González L; Valls A; Buendía E
    Allergol Immunopathol (Madr); 1993; 21(4):136-40. PubMed ID: 8237717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-lymphocyte analysis in cardiac allograft recipients treated with cyclosporine.
    Kawaguchi A; Mohanakumar T; Lee HM; Thompson JA; Lower RR
    Ann Thorac Surg; 1986 Nov; 42(5):517-22. PubMed ID: 2946267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature of the suppressor cells mediating prolonged graft survival after administration of extracted histocompatibility antigen and cyclosporine.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Feb; 39(2):162-8. PubMed ID: 3155879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
    Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL
    Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunosuppressive action of suppressor cells from antigen-cyclosporine-treated hosts on renal allograft survival.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Oct; 40(4):384-9. PubMed ID: 2413593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular target of cyclosporin A action in humans.
    Van Buren CT; Kerman R; Agostino G; Payne W; Flechner S; Kahan BD
    Surgery; 1982 Aug; 92(2):167-74. PubMed ID: 6213052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of thymus differential ratio in immunologic status of graft tolerance.
    Otani Y; Höfer M; Preissinger H; Lie TS
    Res Exp Med (Berl); 1988; 188(4):305-17. PubMed ID: 3065860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.